Report cover image

Europe Medical Foods for Inborn Errors of Metabolism Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published Jun 01, 2023
Length 365 Pages
SKU # DAABD18055200

Description

Europe Medical Foods for Inborn Errors of Metabolism Market - Industry Trends and Forecast to 2030


The Europe medical foods for inborn errors of metabolism market is expected to reach USD 1,560.13 million by 2030, from USD 603.83 million in 2022 growing at the CAGR of 12.8% during the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation
Europe Medical Foods for Inborn Errors of Metabolism Market, By Products (Amino Acid, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, Low Protein Food, and Others), Age Group (Infants, Weaning, Adolescent, and Adults), Diseases (Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria, Methylmalonic Acidemia, Organic Acidurias, Propionic Acidemia, Isovaleric Acidemia, Disorders of Leucine Metabolism, Glutaric Acidemia Type I Renal Disease, Tyrosinemia Types I and II, Urea Cycle Disorders, and Others), Forms (Powder, Liquid, Tablets, Gels, and Others), Packaging (Can, Jar, Packets, Bottle, and Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Drug Stores, Online Pharmacy, and Others), Country (Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Poland, Denmark Belgium, Russia, Turkey, and Rest of Europe) – Industry Trends and Forecast to 2030

Overview of Europe Medical Foods for Inborn Errors of Metabolism Market Dynamics

Driver
• Increasing spending on medical food products
Restraint

• Stringent regulations for medical foods

Opportunity

• Rising preference for dietary supplements over Enzyme Replacement Therapy (ERT)

Market Players

Some of the major market players operating in the Europe medical foods for inborn errors of metabolism are:

• Abbott
• Nestlé Health Science (A Subsidiary of Nestlé)
• Ajinomoto Cambrooke, Inc. (A Subsidiary of Ajinomoto Co., Inc.)
• Mead Johnson & Company, LLC. (A Subsidiary of Reckitt Benckiser Group plc.)
• Nutricia (A Subsidiary of Danone)
• Baxter
• Fresenius Kabi AG (Subsidiary of Fresenius SE & Co. KGaA)
• Meiji Holdings Co., Ltd.
• B. Braun SE
• Dr. Schär AG / SPA
• Kate Farms
• Hexagonnutrition Ltd.
• Primus Pharmaceuticals, Inc.
• Ener-G Foods, Inc.
• PKU Perspectives
• Piam Farmaceutici S.P.A.
• Promin Metabolics
• Orpharma Pty Ltd.
• Pristine Organics Private Limited
• Solace Nutrition
• EBM Medical
• Galen Limited
• PKU-Mdmil
• APR

Table of Contents

365 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Products Lifeline Curve
2.8 Dbmr Market Position Grid
2.9 Secondary Sources
2.10 Assumptions
3 Executive Summary
4 Premium Insight
4.1 Pestel Analysis
4.2 Porter's Five Forces Model
4.3 Europe Medical Foods For Inborn Errors Of Metabolism Market Analysis
4.4 Patent Analysis
5 Pipeline Analysis
6 Epidemiology
7 Industry Insights
7.1 Demographic Trends
7.2 Key Pricing Strategies
7.3 Key Patient Enrollment Strategies
8 Regulatory Scenario For Medical Food
9 Market Overview
9.1 Drivers
9.1.1 Rising Incidences Of Inborn Errors Of Metabolism (Iem)
9.1.2 Rising Preference For Dietary Supplements Over Enzyme Replacement Therapy (Ert)
9.1.3 Increase In The Number Of New-born Screening Procedures
9.1.4 Increasing Spending On Medical Food Products
9.2 Restraints
9.2.1 High Cost Of Medical Foods
9.2.2 Stringent Regulations For Medical Foods
9.3 Opportunities
9.3.1 Government Initiatives And Programs For Creating Awareness About Inborn Errors Of Metabolism
9.3.2 Increasing Collaborations And Partnerships In The Market
9.3.3 Expansion Of Medical Foods In Emerging Markets
9.4 Challenges
9.4.1 Poor Accessibility Of Medical Foods
9.4.2 Alternative Treatment Approaches For Inborn Errors Of Metabolism
10 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Products
10.1 Overview
10.2 Amino Acid
10.2.1 Amino Acid Mixtures
10.2.1.1 Phenylade
10.2.1.1.1 Drink Mix
10.2.1.1.2 Gmp Mix-in
10.2.1.1.3 Gmp Ready
10.2.1.1.4 Others
10.2.1.2 Periflex
10.2.1.3 Lophlex
10.2.1.4 Phlexy
10.2.1.5 Cooler
10.2.1.6 Anamix
10.2.1.7 Lysine-free, Low Tryptophan
10.2.1.8 Glutarade Essential Ga-1
10.2.1.9 Glutarade Ga-1 Amino Acid Blend
10.2.1.10 Glytactin With Gmp
10.2.1.11 Essential Amino Acid Mix
10.2.1.12 Liquigen
10.2.1.13 Msud Gel
10.2.1.14 Others
10.2.2 Single Amino Acid
10.2.2.1 L-arginine
10.2.2.2 L-isoleucine
10.2.2.3 L-tyrosine
10.2.2.4 L-leucine
10.2.2.5 Glycine
10.2.2.6 L-aspartic Acid
10.2.2.7 L-citrulline
10.2.2.8 Others
10.3 Low Protein Food
10.3.1 Low-protein Baking Mixes And Flour Substitutes, Such As Rice Flour Or Potato Flour
10.3.2 Low-protein Energy Bars And Snacks
10.3.3 Low-protein Cereals And Breakfast Food
10.3.4 Low-protein Milk Substitutes, Such As Rice Milk Or Almond Milk
10.3.5 Low-protein Bread, Pasta, And Other Grain-based Products
10.3.6 Others
10.4 Glytactin With Gmp Amino Acid-modified Infant Formula With Iron
10.4.1 By Flavour
10.4.1.1 Vanilla
10.4.1.2 Berry
10.4.1.3 Orange
10.4.1.4 Plain
10.4.1.5 Others
10.4.2 By Usage
10.4.2.1 Ready To Drink
10.4.2.2 Need Dilution/Preparation
10.5 Low-calcium/Vitamin D-free Infant Formula With Iron
10.5.1 No Calcium Or Vitamin D
10.5.2 Low Calcium, No Vitamin D
10.5.3 Others
10.6 Others
11 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Diseases
11.1 Overview
11.2 Phenylketonuria (Pku)
11.2.1 Phenylade
11.2.2 Periflex
11.2.3 Lophlex
11.2.4 Others
11.3 Tyrosinemia Types I And Ii
11.4 Maple Syrup Urine Disease (Msud)
11.4.1 Anamix
11.4.2 Cooler
11.4.3 Msud Gel
11.4.4 Amino Acid Blend
11.4.5 Maxmum
11.4.6 Others
11.5 Homocystinuria
11.6 Glutaric Acidemia Type I
11.7 Urea Cycle Disorders
11.7.1 Ornithine Transcarbamylase Deficiency (Otc)
11.7.2 Carbamyl Phosphate Synthetase Deficiency (Cps)
11.7.3 Citrullinaemia
11.7.4 N-acetylglutamate Synthetase Deficiency (Nags)
11.7.5 Arginase Deficiency (Ag)
11.7.6 Argininosuccinic Aciduria (Asa)
11.7.7 Others
11.8 Methylmalonic Acidemia
11.9 Isovaleric Acidemia
11.10 Organic Acidurias
11.11 Renal Disease
11.12 Propionic Acidemia
11.13 Disorders Of Leucine Metabolism
11.14 Others
12 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Age Group
12.1 Overview
12.2 Infants
12.3 Weaning
12.4 Adolescent
12.5 Adults
13 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Forms
13.1 Overview
13.2 Powder
13.3 Liquid
13.4 Tablets
13.5 Gels
13.6 Others
14 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Packaging
14.1 Overview
14.2 Can
14.3 Packets
14.4 Bottle
14.5 Jar
14.6 Others
15 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel
15.1 Overview
15.2 Hospital Pharmacy
15.3 Retail Pharmacy
15.4 Drug Stores
15.5 Online Pharmacy
15.6 Others
16 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Region
16.1 Europe
16.1.1 Germany
16.1.2 France
16.1.3 U.K.
16.1.4 Italy
16.1.5 Spain
16.1.6 Switzerland
16.1.7 Netherlands
16.1.8 Belgium
16.1.9 Denmark
16.1.10 Russia
16.1.11 Sweden
16.1.12 Turkey
16.1.13 Poland
16.1.14 Finland
16.1.15 Norway
16.1.16 Rest Of Europe
17 Europe Medical Foods For Inborn Errors Of Metabolism Market, Company Landscape
17.1 Company Share Analysis: Europe
18 Swot Analysis
19 Company Profile
19.1 Abbott
19.1.1 Company Snapshot
19.1.2 Revenue Analysis
19.1.3 Company Share Analysis
19.1.4 Product Portfolio
19.1.5 Recent Development
19.2 Nestlé Health Science (A Subsidiary Of Nestlé)
19.2.1 Company Snapshot
19.2.2 Company Share Analysis
19.2.3 Product Portfolio
19.2.4 Recent Development
19.3 Ajinomoto Cambrooke, Inc. (A Subsidiary Of Ajinomoto Co., Inc.)
19.3.1 Company Snapshot
19.3.2 Company Share Analysis
19.3.3 Product Portfolio
19.3.4 Recent Developments
19.4 Mead Johnson & Company, Llc. (A Subsidiary Of Reckitt Benckiser Group Plc.)
19.4.1 Company Snapshot
19.4.2 Company Share Analysis
19.4.3 Product Portfolio
19.4.4 Recent Development
19.5 Nutricia (A Subsidiary Of Danone)
19.5.1 Company Snapshot
19.5.2 Company Share Analysis
19.5.3 Product Portfolio
19.5.4 Recent Development
19.6 Apr
19.6.1 Company Snapshot
19.6.2 Product Portfolio
19.6.3 Recent Development
19.7 B.Braun Se
19.7.1 Company Snapshot
19.7.2 Product Portfolio
19.7.3 Recent Development
19.8 Baxter
19.8.1 Company Snapshot
19.8.2 Revenue Analysis
19.8.3 Product Portfolio
19.8.4 Recent Development
19.9 Dr. Schär Ag / Spa
19.9.1 Company Snapshot
19.9.2 Product Portfolio
19.9.3 Recent Development
19.10 Ebm Medical
19.10.1 Company Snapshot
19.10.2 Product Portfolio
19.10.3 Recent Development
19.11 Ener-g Foods, Inc.
19.11.1 Company Snapshot
19.11.2 Product Portfolio
19.11.3 Recent Development
19.12 Fresenius Kabi Ag (Subsidiary Of Fresenius Se & Co. Kgaa)
19.12.1 Company Snapshot
19.12.2 Product Portfolio
19.12.3 Recent Development
19.13 Galen Limited
19.13.1 Company Snapshot
19.13.2 Product Portfolio
19.13.3 Recent Developments
19.14 Hexagonnutrition Ltd.
19.14.1 Company Snapshot
19.14.2 Product Portfolio
19.14.3 Recent Development
19.15 Kate Farms
19.15.1 Company Snapshot
19.15.2 Product Portfolio
19.15.3 Recent Developments
19.16 Meiji Holdings Co., Ltd.
19.16.1 Company Snapshot
19.16.2 Revenue Analysis
19.16.3 Product Portfolio
19.16.4 Recent Development
List Of Tables
Table 1 Europe Medical Foods For Inborn Errors Of Metabolism Market, Patent Analysis
Table 2 Europe Medical Foods For Inborn Errors Of Metabolism Market, Pipeline Analysis
Table 3 Costs Of Medical Foods Used In Inborn Errors Of Metabolism (Iems)
Table 4 The Manufacturing Of Medical Food Must Comply With The Below Given Fda Requirement:
Table 5 Costs Of Medical Foods
Table 6 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-20307 (Usd Million)
Table 7 Europe Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 8 Europe Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 9 Europe Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 10 Europe Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 11 Europe Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 12 Europe Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2030 (Usd Million)
Table 13 Europe Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 14 Europe Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 15 Europe Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavours, 2021-2030 (Usd Million)
Table 16 Europe Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usage, 2021-2030 (Usd Million)
Table 17 Europe Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 18 Europe Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 19 Europe Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 20 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 21 Europe Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 22 Europe Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 23 Europe Tyrosinemia Types I And Ii In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 24 Europe Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 25 Europe Maple Syrup Urine Disease(Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2030 (Usd Million)
Table 26 Europe Homocystinuria In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 27 Europe Glutaric Acidemia Type I In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 28 Europe Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 29 Europe Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 30 Europe Methylmalonic Acidemia In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 31 Europe Isovaleric Acidemia In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 32 Europe Organic Acidurias In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 33 Europe Renal Disease In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2030 (Usd Million)
Table 34 Europe Propionic Acidemia In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 35 Europe Disorders Of Leucine Metabolism In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 36 Europe Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 37 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2021-2030 (Usd Million)
Table 38 Europe Infants In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 39 Europe Weaning In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 40 Europe Adolescent In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 41 Europe Adults In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 42 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2021-2030 (Usd Million)
Table 43 Europe Powder In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 44 Europe Liquid In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 45 Europe Tablets In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 46 Europe Gels In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 47 Europe Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 48 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2021-2030 (Usd Million)
Table 49 Europe Can In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 50 Europe Packets In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 51 Europe Bottle In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 52 Europe Jar In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 53 Europe Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 54 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 55 Europe Hospital Pharmacy In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 56 Europe Retail Pharmacy In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 57 Europe Drug Stores In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 58 Europe Online Pharmacy In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 59 Europe Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2021-2030 (Usd Million)
Table 60 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Country, 2021-2030 (Usd Million)
Table 61 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 62 Europe Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 63 Europe Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 64 Europe Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 65 Europe Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 66 Europe Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 67 Europe Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2021-2030 (Usd Million)
Table 68 Europe Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2021-2030 (Usd Million)
Table 69 Europe Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 70 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 71 Europe Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 72 Europe Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 73 Europe Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 74 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2021-2030 (Usd Million)
Table 75 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2021-2030 (Usd Million)
Table 76 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2021-2030 (Usd Million)
Table 77 Europe Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 78 Germany Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 79 Germany Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 80 Germany Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 81 Germany Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 82 Germany Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 83 Germany Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 84 Germany Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2021-2030 (Usd Million)
Table 85 Germany Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2021-2030 (Usd Million)
Table 86 Germany Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 87 Germany Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 88 Germany Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 89 Germany Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 90 Germany Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 91 Germany Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2021-2030 (Usd Million)
Table 92 Germany Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2021-2030 (Usd Million)
Table 93 Germany Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2021-2030 (Usd Million)
Table 94 Germany Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 95 France Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 96 France Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 97 France Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 98 France Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 99 France Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 100 France Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 101 France Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2021-2030 (Usd Million)
Table 102 France Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2021-2030 (Usd Million)
Table 103 France Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 104 France Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 105 France Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 106 France Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 107 France Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 108 France Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2021-2030 (Usd Million)
Table 109 France Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2021-2030 (Usd Million)
Table 110 France Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2021-2030 (Usd Million)
Table 111 France Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 112 U.K. Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 113 U.K. Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 114 U.K. Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 115 U.K. Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 116 U.K. Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 117 U.K. Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 118 U.K. Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2021-2030 (Usd Million)
Table 119 U.K. Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2021-2030 (Usd Million)
Table 120 U.K. Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 121 U.K. Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 122 U.K. Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 123 U.K. Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 124 U.K. Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2021-2030 (Usd Million)
Table 125 U.K. Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2021-2030 (Usd Million)
Table 126 U.K. Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2021-2030 (Usd Million)
Table 127 U.K. Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2021-2030 (Usd Million)
Table 128 U.K. Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 129 Italy Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
Table 130 Italy Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2021-2030 (Usd Million)
List Of Figures
Figure 1 Europe Medical Foods For Inborn Errors Of Metabolism Market: Segmentation
Figure 2 Europe Medical Foods For Inborn Errors Of Metabolism Market: Data Triangulation
Figure 3 Europe Medical Foods For Inborn Errors Of Metabolism Market: Droc Analysis
Figure 4 Europe Medical Foods For Inborn Errors Of Metabolism Market: Europe Vs Regional Market Analysis
Figure 5 Europe Medical Foods For Inborn Errors Of Metabolism Market: Company Research Analysis
Figure 6 Europe Medical Foods For Inborn Errors Of Metabolism Market: Interview Demographics
Figure 7 Europe Medical Foods For Inborn Errors Of Metabolism Market: Dbmr Market Position Grid
Figure 8 Europe Medical Foods For Inborn Errors Of Metabolism Market: Segmentation
Figure 9 A Rise In The Incidence Of Inborn Errors Of Metabolism And An Increase In The Number Of The Newborn Screening Procedures Are Expected To Drive The Europe Medical Foods For Inborn Errors Of Metabolism Market Growth In The Forecast Period Of 2023 To 2030
Figure 10 The Amino Acid Segment Is Expected To Account For The Largest Share Of The Europe Medical Foods For Inborn Errors Of Metabolism Market In 2023 And 2030
Figure 11 Drivers, Restraints, Opportunities, And Challenges Of The Europe Medical Foods For Inborn Errors Of Metabolism Market
Figure 12 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Products, 2022
Figure 13 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Products, 2023-2030 (Usd Million)
Figure 14 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Products, Cagr (2023-2030)
Figure 15 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Products, Lifeline Curve
Figure 16 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Diseases, 2022
Figure 17 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Diseases, 2023-2030 (Usd Million)
Figure 18 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Diseases, Cagr (2023-2030)
Figure 19 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Diseases, Lifeline Curve
Figure 20 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Age Group, 2022
Figure 21 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Age Group, 2023-2030 (Usd Million)
Figure 22 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Age Group, Cagr (2023-2030)
Figure 23 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Age Group, Lifeline Curve
Figure 24 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Forms, 2022
Figure 25 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Forms, 2023-2030 (Usd Million)
Figure 26 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Forms, Cagr (2023-2030)
Figure 27 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Forms, Lifeline Curve
Figure 28 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Packaging, 2022
Figure 29 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Packaging, 2023-2030 (Usd Million)
Figure 30 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Packaging, Cagr (2023-2030)
Figure 31 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Packaging, Lifeline Curve
Figure 32 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Distribution Channel, 2022
Figure 33 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 34 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Distribution Channel, Cagr (2023-2030)
Figure 35 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Distribution Channel, Lifeline Curve
Figure 36 Europe Medical Foods For Inborn Errors Of Metabolism Market: Snapshot (2022)
 
Figure 37 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Country (2022)
Figure 38 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Country (2023 & 2030)
Figure 39 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Country (2022 & 2030)
Figure 40 Europe Medical Foods For Inborn Errors Of Metabolism Market: By Products (2023-2030)
Figure 41 Europe Medical Foods For Inborn Errors Of Metabolism Market: Company Share 2022 (%) 292

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us